{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:33:18Z","timestamp":1785429198832,"version":"3.56.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.molmed.2023.12.001","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T21:14:46Z","timestamp":1703020486000},"page":"321-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3116-8175","authenticated-orcid":false,"given":"Trevor","family":"Steward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2023.12.001_bb0005","first-page":"864","article-title":"Large-scale exploration of whole-brain structural connectivity in anorexia nervosa: alterations in the connectivity of frontal and subcortical networks","volume":"8","author":"Lloyd","year":"2022","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.molmed.2023.12.001_bb0010","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1176\/appi.ajp.2019.19030261","article-title":"Neural insensitivity to the effects of hunger in women remitted from anorexia nervosa","volume":"177","author":"Kaye","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.molmed.2023.12.001_bb0015","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1017\/S0033291722000198","article-title":"Altered prefrontal activation during the inhibition of eating responses in women with bulimia nervosa","volume":"53","author":"Berner","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.molmed.2023.12.001_bb0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jpsychires.2023.03.004","article-title":"Aberrant reward-related neural activation: dimensional correlate of binge-eating severity or categorical marker of binge eating?","volume":"161","author":"Hagan","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.molmed.2023.12.001_bb0025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1556\/2006.2021.00023","article-title":"The neural correlates of delay discounting in obesity and binge eating disorder","volume":"10","author":"Miranda-Olivos","year":"2021","journal-title":"J. Behav. Addict."},{"key":"10.1016\/j.molmed.2023.12.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113071","article-title":"Reward and psychopathological correlates of eating disorders: the explanatory role of leptin","volume":"290","author":"Cassioli","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.molmed.2023.12.001_bb0035","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1038\/s41598-019-44450-6","article-title":"Reduced plasma orexin-A concentrations are associated with cognitive deficits in anorexia nervosa","volume":"9","author":"Steward","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2023.12.001_bb0040","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s41386-021-01052-z","article-title":"Sleep dysregulation in binge eating disorder and \u201cfood addiction\u201d: the orexin (hypocretin) system as a potential neurobiological link","volume":"46","author":"Mehr","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2023.12.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110303","article-title":"The therapeutic potential of GLP-1 analogues for stress-related eating and role of GLP-1 in stress, emotion and mood: a review","volume":"110","author":"Guerrero-Hreins","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2023.12.001_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/osp4.619","article-title":"A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder","volume":"9","author":"Allison","year":"2023","journal-title":"Obes. Sci. Pract."},{"key":"10.1016\/j.molmed.2023.12.001_bb0055","article-title":"Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: a retrospective cohort study","volume":"7","author":"Richards","year":"2023","journal-title":"Obes. Pillars"},{"key":"10.1016\/j.molmed.2023.12.001_bb0060","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1080\/14656566.2023.2271389","article-title":"Exploring the nexus of binge eating disorder (BED), new psychoactive substances (NPS), and misuse of pharmaceuticals: charting a path forward","volume":"24","author":"Chiappini","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.molmed.2023.12.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119408","article-title":"Regional hypothalamic, amygdala, and midbrain periaqueductal gray matter recruitment during acute pain in awake humans: a 7-Tesla functional magnetic resonance imaging study","volume":"259","author":"Robertson","year":"2022","journal-title":"Neuroimage"},{"key":"10.1016\/j.molmed.2023.12.001_bb0070","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/s41591-023-02455-9","article-title":"Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study","volume":"29","author":"Peck","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2023.12.001_bb0075","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491423002800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491423002800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T16:03:57Z","timestamp":1727885037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491423002800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1471491423002800"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2023.12.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}